U.S. Markets closed

Tekla Healthcare Investors (HQH)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
23.42+0.11 (+0.47%)
At close: 04:00PM EST

Tekla Healthcare Investors

100 Federal Street
19th Floor
Boston, MA 02110
United States

Sector(s)Financial Services
IndustryAsset Management
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Dr. Daniel R. Omstead M.S, Ph.D.Portfolio Mang.N/AN/A1953
Dr. Jason C. Akus M.D., MBAVP of Research and Portfolio Mang.N/AN/AN/A
Mr. Christopher F. BrinzeySr. VP of Research and Portfolio Mang.N/AN/AN/A
Dr. Frank T. Gentile Ph.D.Sr. VP of Research and Portfolio Mang.N/AN/A1962
Amounts are as of December 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.

Corporate Governance

Tekla Healthcare Investors’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.